Scutellarein-7-O-glucosideCAS# 26046-94-6 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 26046-94-6 | SDF | Download SDF |
PubChem ID | 5320623 | Appearance | Yellow powder |
Formula | C21H20O11 | M.Wt | 448.4 |
Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 5,6-dihydroxy-2-(4-hydroxyphenyl)-7-[(2~{S},3~{R},4~{S},5~{S},6~{R})-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one | ||
SMILES | C1=CC(=CC=C1C2=CC(=O)C3=C(C(=C(C=C3O2)OC4C(C(C(C(O4)CO)O)O)O)O)O)O | ||
Standard InChIKey | VUGRLRAUZWGZJP-IAAKTDFRSA-N | ||
Standard InChI | InChI=1S/C21H20O11/c22-7-14-17(26)19(28)20(29)21(32-14)31-13-6-12-15(18(27)16(13)25)10(24)5-11(30-12)8-1-3-9(23)4-2-8/h1-6,14,17,19-23,25-29H,7H2/t14-,17-,19+,20-,21-/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Scutellarein-7-O-glucoside inhibites MMP-2 activity. |
Targets | MMP |
In vitro | Engineering Saccharomyces cerevisiae with the deletion of endogenous glucosidases for the production of flavonoid glucosides.[Pubmed: 27491546 ]Microb Cell Fact. 2016 Aug 4;15(1):134.Glycosylation of flavonoids is a promising approach to improve the pharmacokinetic properties and biological activities of flavonoids. Recently, many efforts such as enzymatic biocatalysis and the engineered Escherichia coli biotransformation have increased the production of flavonoid glucosides. However, the low yield of flavonoid glucosides can not meet the increasing demand for human medical and dietary needs. Saccharomyces cerevisiae is a generally regarded as safe (GRAS) organism that has several attractive characteristics as a metabolic engineering platform for the production of flavonoid glucosides. However, endogenous glucosidases of S. cerevisiae as a whole-cell biocatalyst reversibly hydrolyse the glucosidic bond and hinder the biosynthesis of the desired products. In this study, a model flavonoid, scutellarein, was used to exploit how to enhance the production of flavonoid glucosides in the engineered S. cerevisiae.
The influence of selected flavonoids from the leaves of Cirsium palustre (L.) Scop. on collagen expression in human skin fibroblasts.[Pubmed: 24643916 ]Phytother Res. 2014 Sep;28(9):1399-405.Ten flavonoids belonging to the subclasses of flavones, flavanones and aurones were isolated from methanolic extract of Cirsium palustre leaves after multistep chromatographic separation. Their structures were elucidated with spectroscopic methods.
|
Structure Identification | Nat Prod Commun. 2015 Mar;10(3):403-5.Foliar flavonoids from Tanacetum vulgare var. boreale and their geographical variation.[Pubmed: 25924515]
|
Scutellarein-7-O-glucoside Dilution Calculator
Scutellarein-7-O-glucoside Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.2302 mL | 11.1508 mL | 22.3015 mL | 44.603 mL | 55.7538 mL |
5 mM | 0.446 mL | 2.2302 mL | 4.4603 mL | 8.9206 mL | 11.1508 mL |
10 mM | 0.223 mL | 1.1151 mL | 2.2302 mL | 4.4603 mL | 5.5754 mL |
50 mM | 0.0446 mL | 0.223 mL | 0.446 mL | 0.8921 mL | 1.1151 mL |
100 mM | 0.0223 mL | 0.1115 mL | 0.223 mL | 0.446 mL | 0.5575 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Steviol-19-O-Glucoside
Catalog No.:BCN6373
CAS No.:1185737-16-9
- (-)-Epiafzelechin 3-O-gallate
Catalog No.:BCN8740
CAS No.:108907-43-3
- 8-Hydroxypinoresinol diglucoside
Catalog No.:BCN6368
CAS No.:112747-99-6
- Caraganaphenol A
Catalog No.:BCN8731
CAS No.:174916-31-5
- Cyclocurcumin
Catalog No.:BCN6379
CAS No.:153127-42-5
- Daidzein-4',7-diglucoside
Catalog No.:BCN8135
CAS No.:53681-67-7
- Quercetagetin
Catalog No.:BCN8729
CAS No.:90-18-6
- Osmundacetone
Catalog No.:BCN8739
CAS No.:123694-03-1
- 1-Methyl-2,8-dihydroxy-3-carboxy-9,10-anthraquinone
Catalog No.:BCN8727
CAS No.:1401414-53-6
- Quercetin 3-O-(6''-galloyl)-beta-D-galactopyranoside
Catalog No.:BCN6381
CAS No.:53171-28-1
- Physalin O
Catalog No.:BCN8710
CAS No.:120849-18-5
- N-(3-Methoxybenzyl)(9Z,12Z,15Z)-octadeca-9,12,15-trienamide
Catalog No.:BCN6439
CAS No.:383715-23-9
- Quercetin 3-O-(6''-galloyl)-beta-D-glucopyranoside
Catalog No.:BCN8742
CAS No.:56316-75-7
- (R)-alpha-methyltryptamine
Catalog No.:BCN8160
CAS No.:7795-52-0
- 2''-O-acetylsaikosaponin A
Catalog No.:BCN8736
CAS No.:102934-42-9
- Trillikamtoside Q
Catalog No.:BCN8195
CAS No.:2098642-70-5
- Xanthoangelol
Catalog No.:BCN8741
CAS No.:62949-76-2
- Arecaidine
Catalog No.:BCN8282
CAS No.:499-04-7
- Isosilybin B
Catalog No.:BCN6764
CAS No.:142796-22-3
- Luteolin-3',7-di-O-glucoside
Catalog No.:BCN6380
CAS No.:257-724-7
- Isosilybin A
Catalog No.:BCN6369
CAS No.:142796-21-2
- Cistantubuloside C1
Catalog No.:BCN6362
CAS No.:620632-36-2
- Niga-ichigoside F1
Catalog No.:BCN8356
CAS No.:95262-48-9
- 1,3,6-Trihydroxy-2-methylanthraquinone 3-O-alpha-L-rhamnosyl-(1->2)-beta-D-glucoside
Catalog No.:BCN8732
CAS No.:87686-88-2